Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angus G Jones

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
The Lancet. Global Health|September 20, 2025
Classifying a distinct form of diabetes in lean individuals with a history of undernutrition: an international consensus statementPradnyashree Wadivkar, Felix Jebasingh, Nihal Thomas, et al.
The Lancet. Diabetes & Endocrinology|December 17, 2022
Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trialsAdem Y Dawed, Andrea Mari, Andrew Brown, et al.
Diabetes Care|October 25, 2018
A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin TherapyAnita L Grubb, Timothy J McDonald, Femke Rutters, et al.
Diabetologia|September 30, 2024
Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT studySapna Sharma, Qiuling Dong, Mark Haid, et al.
Medrxiv : the Preprint Server for Health Sciences|April 24, 2023
Type 2 Diabetes risk alleles in Peptidyl-glycine Alpha-amidating Monooxygenase influence GLP-1 levels and response to GLP-1 Receptor AgonistsMahesh M Umapathysivam, Elisa Araldi, Benoit Hastoy, et al.
The Lancet. Global Health|January 10, 2026
Recognising type 5 diabetes - Authors' replyMeredith Hawkins, Peter Schwarz, Chittaranjan S Yajnik, et al.
The Lancet. Diabetes & Endocrinology|July 24, 2025
Non-autoimmune, insulin-deficient diabetes in children and young adults in Africa: evidence from the Young-Onset Diabetes in sub-Saharan Africa (YODA) cross-sectional studyJean Claude Katte, Steven Squires, Mesmin Y Dehayem, et al.
The Journal of Clinical Endocrinology and Metabolism|September 18, 2020
Genome-Wide Association Analysis of Pancreatic Beta-Cell Glucose SensitivityHarshal A Deshmukh, Anne Lundager Madsen, Ana Viñuela, et al.
Plos Genetics|July 15, 2025
Bayesian network imputation methods applied to multi-omics data identify putative causal relationships in a type 2 diabetes dataset containing incomplete data: An IMI DIRECT StudyRichard Howey, Jonathan Adam, Jerzy Adamski, et al.
Genome Medicine|March 29, 2026
Type 2 diabetes risk alleles in peptidyl-glycine alpha-amidating monooxygenase influence GLP-1 levels and response to GLP-1 receptor agonistsMahesh M Umapathysivam, Elisa Araldi, Benoit Hastoy, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
The Lancet. Global Health|September 20, 2025
Classifying a distinct form of diabetes in lean individuals with a history of undernutrition: an international consensus statementPradnyashree Wadivkar, Felix Jebasingh, Nihal Thomas, et al.
The Lancet. Diabetes & Endocrinology|December 17, 2022
Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trialsAdem Y Dawed, Andrea Mari, Andrew Brown, et al.
Diabetes Care|October 25, 2018
A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin TherapyAnita L Grubb, Timothy J McDonald, Femke Rutters, et al.
Diabetologia|September 30, 2024
Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT studySapna Sharma, Qiuling Dong, Mark Haid, et al.
Medrxiv : the Preprint Server for Health Sciences|April 24, 2023
Type 2 Diabetes risk alleles in Peptidyl-glycine Alpha-amidating Monooxygenase influence GLP-1 levels and response to GLP-1 Receptor AgonistsMahesh M Umapathysivam, Elisa Araldi, Benoit Hastoy, et al.
The Lancet. Global Health|January 10, 2026
Recognising type 5 diabetes - Authors' replyMeredith Hawkins, Peter Schwarz, Chittaranjan S Yajnik, et al.
The Lancet. Diabetes & Endocrinology|July 24, 2025
Non-autoimmune, insulin-deficient diabetes in children and young adults in Africa: evidence from the Young-Onset Diabetes in sub-Saharan Africa (YODA) cross-sectional studyJean Claude Katte, Steven Squires, Mesmin Y Dehayem, et al.
The Journal of Clinical Endocrinology and Metabolism|September 18, 2020
Genome-Wide Association Analysis of Pancreatic Beta-Cell Glucose SensitivityHarshal A Deshmukh, Anne Lundager Madsen, Ana Viñuela, et al.
Plos Genetics|July 15, 2025
Bayesian network imputation methods applied to multi-omics data identify putative causal relationships in a type 2 diabetes dataset containing incomplete data: An IMI DIRECT StudyRichard Howey, Jonathan Adam, Jerzy Adamski, et al.
Genome Medicine|March 29, 2026
Type 2 diabetes risk alleles in peptidyl-glycine alpha-amidating monooxygenase influence GLP-1 levels and response to GLP-1 receptor agonistsMahesh M Umapathysivam, Elisa Araldi, Benoit Hastoy, et al.
Pageof 10